Inger Hee Mabuza Mathiesen
Overview
Explore the profile of Inger Hee Mabuza Mathiesen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nielsen B, Mikkelsen C, Oturai P, Krogh-Madsen R, Katzenstein T, Ritz C, et al.
Front Endocrinol (Lausanne)
. 2024 Nov;
15:1382241.
PMID: 39530118
Objective: We hypothesized that the insulin-sensitizing adipokine adiponectin (ADP) is upregulated in cystic fibrosis (CF) related diabetes (CFRD) and underweight adults with CF. We aimed to assess correlations between glucose...
2.
Hornung L, Hamm S, Hald A, Harboe Z, Lundbo L, Wareham N, et al.
Vaccines (Basel)
. 2024 Oct;
12(10).
PMID: 39460259
Vaccination before solid organ transplantation is recommended since post-transplantation immunosuppression is known to impair vaccine responses. However, little is known about post-transplantation seroprotection rates in organ transplant recipients vaccinated pre-transplantation....
3.
Bryrup T, Faurholt-Jepsen D, Pressler T, Henriksen E, Leo-Hansen C, Nielsen B, et al.
APMIS
. 2024 Aug;
132(10):728-733.
PMID: 39092470
Sweat chloride concentration, a diagnostic feature in cystic fibrosis (CF), reflects CF transmembrane conductance regulator (CFTR) activity. CFTR modulator therapies, especially elexacaftor/tezacaftor/ivacaftor (ETI), has improved CF outcomes. We report nationwide,...
4.
Qvist T, Nielsen B, Olesen H, Mathiesen I, Faurholt-Jepsen D, Katzenstein T, et al.
APMIS
. 2024 Jan;
132(4):223-235.
PMID: 38267398
Cystic fibrosis (CF) care in Denmark has been characterized by close monitoring and pre-emptive treatment of lung disease and other CF-related complications. Continuous evaluation through data collection and commitment to...
5.
Nielsen B, Olsen M, Mathiesen I, Pressler T, Ritz C, Katzenstein T, et al.
J Cyst Fibros
. 2023 Nov;
23(1):103-108.
PMID: 37989700
Background: Elexacaftor/tezacaftor/ivacaftor (ETI) has improved the clinical status of individuals with cystic fibrosis (CF), however, whether ETI impacts glucose tolerance remains unknown. We aimed to study the change in glycated...
6.
Nielsen B, Mathiesen I, Moller R, Krogh-Madsen R, Katzenstein T, Pressler T, et al.
Front Endocrinol (Lausanne)
. 2023 Sep;
14:1249876.
PMID: 37720541
Aims: The purpose of the study was to further elucidate the pathophysiology of cystic fibrosis (CF)-related diabetes (CFRD) and potential drivers of hypoglycaemia. Hence, we aimed to describe and compare...
7.
Ekblond R, Nielsen B, Hojte C, Almdal T, Shaw J, Pressler T, et al.
Pediatr Pulmonol
. 2023 Jun;
58(9):2600-2609.
PMID: 37341613
Background: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have been shown to have a beneficial effect on pulmonary function and nutritional status in patients with cystic fibrosis (CF), but the...
8.
Jensen P, Nielsen B, Kolpen M, Pressler T, Faurholt-Jepsen D, Mathiesen I
APMIS
. 2022 May;
130(8):535-539.
PMID: 35635299
Blood glucose levels exceeding 8 mM are shown to increase glucose levels in airway surface in cystic fibrosis (CF). Moreover, high levels of endobronchial glucose are proposed to increase the...
9.
Kolpen M, Kragh K, Enciso J, Faurholt-Jepsen D, Lindegaard B, Egelund G, et al.
Thorax
. 2022 Jan;
77(10):1015-1022.
PMID: 35017313
Background: A basic paradigm of human infection is that acute bacterial disease is caused by fast growing planktonic bacteria while chronic infections are caused by slow-growing, aggregated bacteria, a phenomenon...
10.
Nielsen B, Faurholt-Jepsen D, Oturai P, Qvist T, Krogh-Madsen R, Katzenstein T, et al.
Clin Med Insights Endocrinol Diabetes
. 2021 Aug;
14:11795514211038259.
PMID: 34413690
Background: A frequent comorbidity in cystic fibrosis (CF) is CF related diabetes (CFRD) caused by a gradual decline in insulin secretion. The reduction in the anabolic hormone, insulin, might explain...